Organogenesis Holdings Inc. (ORGO) Social Stream
Organogenesis Holdings Inc (ORGO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Organogenesis Holdings Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 14 months, ORGO's average price target has gone up $7.5.
Over the past 46 weeks, ORGO's average upside potential has been 73.69%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ORGO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ORGO as an investment opportunity.
- Organogenesis Holdings Inc's number of analysts covering the stock is greater than 14.13% of all US stocks.
- Organogenesis Holdings Inc's upside potential (average analyst target price relative to current price) is higher than 445.31% of stocks in the mid market cap category.
- ORGO has a higher average analyst price target than 118.2% of stocks in the mid market cap category.
- In the context of Pharmaceutical Products stocks, Organogenesis Holdings Inc's variance in analysts' estimates is lower than -46.34% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Organogenesis Holdings Inc are OPK, OGN, and NUVB.
Is ORGO a Buy, Hold or Sell? See the POWR Ratings now!